ChartRow logo
PeersMRNALLYMDTUNHJNJTMO
Share this page

AXGN financial statements

The full income statement, balance sheet, and cash-flow statement for Axogen Inc. (AXGN), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 43.8M2024-09 44.0M2024-12 44.3M2025-03 45.5M2025-06 46.0M2025-09 46.1M2025-12 51.9M2026-03 53.2M2026-06 53.8M+22.7% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

PeriodRangeOrderChangeFiguresAs-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue225M+20.2%187M+17.8%159M+14.7%139M+8.8%127M+13.4%
167M+17.9%142M+16.5%122M+12.0%109M+4.2%104M+15.1%
Cost of revenue57.9M+27.5%45.4M+22.1%37.1M+24.7%29.8M+29.8%22.9M+6.3%
Research & development32.9M+18.4%27.8M+1.6%27.3M+6.7%25.6M+6.0%24.2M+35.5%
Selling, general & administrative44.6M+14.2%39.0M+1.6%38.4M-6.1%40.9M+26.5%32.3M+22.5%
General & administrative44.6M+14.2%39.0M+1.6%38.4M-6.1%40.9M+26.5%32.3M+22.5%
Selling & marketing97.7M+24.6%78.5M+1.1%77.6M+7.8%72.0M-1.8%73.3M+5.3%
Amortization of intangibles315K+18.0%267K-2.2%273K+3.0%265K+31.2%202K+32.0%
Provision for credit losses400K-38.5%650K+339.9%-271K-144.3%612K+1592.7%-41.0K+61.0%
Operating income-7.85M-138.8%-3.29M+84.7%-21.5M+27.8%-29.7M-16.9%-25.4M-9.6%
Interest expense7.70M-6.1%8.21M+189.5%2.83M+354.3%624K-54.0%1.36M+28.7%
Other non-operating income167K+183.9%-199K+54.5%-437K-90.0%-230K+17.3%-278K-631.6%
Income tax0.000.000.000.000.00
Net income-15.7M-57.6%-9.96M+54.1%-21.7M+25.0%-28.9M-7.3%-27.0M-13.4%
-$0.34-47.8%-$0.23+54.9%-$0.51+26.1%-$0.69-6.2%-$0.65-8.3%
EPS (basic)-$0.34-47.8%-$0.23+54.9%-$0.51+26.1%-$0.69-6.2%-$0.65-8.3%
Weighted-avg shares (basic)46.1M+4.1%44.3M+3.2%42.9M+1.9%42.1M+2.1%41.2M+3.1%
Weighted-avg shares (diluted)46.1M+4.1%44.3M+3.2%42.9M+1.9%42.1M+2.1%41.2M+3.1%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
120M+21.4%99.2M+12.7%88.0M-10.3%98.1M-22.8%127M-12.5%
Cash & equivalents35.5M+29.0%27.6M-11.2%31.0M+103.0%15.3M-53.3%32.8M-32.8%
Short-term investments5.98M+0.9%5.93M0.00-100.0%33.5M-34.7%51.3M-7.0%
Accounts receivable26.2M+8.6%24.1M-4.1%25.1M+13.3%22.2M+22.2%18.2M+3.1%
Inventory42.4M+27.7%33.2M+44.1%23.0M+21.8%18.9M+13.3%16.7M+33.2%
Prepaid expenses6.35M+159.6%2.45M-12.9%2.81M+44.6%1.94M+4.5%1.86M-56.7%
222M+8.8%204M+3.5%197M+0.7%195M-6.1%208M+3.3%
Property, plant & equipment
————62.9M+63.8%
Operating lease right-of-use12.7M-10.7%14.3M-8.3%15.6M+8.3%14.4M-5.4%15.2M-2.7%
Intangible assets6.75M+21.0%5.58M+23.1%4.53M+24.2%3.65M+27.6%2.86M+39.2%
Other non-current assets
0.00————
23.6M-23.0%30.6M+0.6%30.4M+28.1%23.8M-2.2%24.3M+6.4%
Accounts payable2.89M-63.9%8.01M-32.0%11.8M+31.3%8.96M+51.3%5.92M+28.8%
Accrued liabilities21.2M-26.0%28.6M-0.8%28.9M+28.7%22.4M-0.1%22.5M+2.2%
Deferred revenue
————14.0K+0.0%
Current lease liability2.35M+20.1%1.96M+27.2%1.54M+18.3%1.30M-28.6%1.82M+115.7%
Finance lease liability (current)18.0K+100.0%9.00K+50.0%6.00K-14.3%7.00K-22.2%9.00K-47.1%
92.8M-7.0%99.8M-1.3%101M+7.2%94.4M-1.1%95.5M+22.0%
Long-term debt48.4M+1.9%47.5M+1.9%46.6M+1.9%45.7M+2.0%44.8M+39.9%
Deferred revenue (non-current)
————0.00-100.0%
Non-current lease liability16.8M-12.3%19.2M-9.1%21.1M+3.6%20.4M-2.0%20.8M-0.3%
Operating lease liability (total)
————22.6M+4.2%
Finance lease liability (total)
————13.0K-56.7%
Finance lease liability32.0K+6.7%30.0K+57.9%19.0K+5.6%18.0K+350.0%4.00K-69.2%
Other non-current liabilities141K+50.0%94.0K0.00—0.00-100.0%
129M+24.0%104M+8.6%95.7M-5.3%101M-10.3%113M-8.6%
Common stock472K+7.0%441K+2.3%431K+1.7%424K+1.7%417K+2.7%
Additional paid-in capital435M+10.3%395M+4.8%377M+4.5%360M+5.1%343M+5.0%
Retained earnings-307M-5.4%-291M-3.5%-281M-8.4%-260M-12.6%-231M-13.3%
Total liabilities & equity222M+8.8%204M+3.5%197M+0.7%195M-6.1%208M+3.3%
Common shares issued47.2M+6.9%44.1M+2.4%43.1M+1.6%42.4M+1.7%41.7M+2.8%
Common shares outstanding47.2M+6.9%44.1M+2.4%43.1M+1.6%42.4M+1.7%41.7M+2.8%
Shares outstanding (cover)51.9M+17.0%44.3M+2.6%43.2M+1.4%42.6M+1.9%41.8M+2.6%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
812K-82.1%4.54M+179.3%-5.72M+64.4%-16.1M-19.9%-13.4M-39.3%
Depreciation & amortization6.66M+3.0%6.47M+53.3%4.22M+49.2%2.83M+3.0%2.74M+79.3%
Intangible amortization315K+18.0%267K-2.2%273K+3.0%265K+31.2%202K+32.0%
Share-based compensation30.1M+89.3%15.9M+10.3%14.4M-7.5%15.6M+42.8%10.9M+28.9%
Change in receivables2.46M+728.6%-392K-114.6%2.69M-42.0%4.64M+829.7%499K-21.4%
Change in inventory9.19M-9.6%10.2M+147.0%4.12M+118.1%1.89M-74.8%7.48M+721.8%
-5.32M+48.4%-10.3M-153.5%19.3M+701.7%-3.20M+86.5%-23.6M-39.4%
Capital expenditure3.75M+20.8%3.10M-77.6%13.9M-30.9%20.1M-27.8%27.8M+27.0%
Free cash flow-2.93M-304.5%1.43M+107.3%-19.6M+45.8%-36.1M+12.3%-41.2M-30.7%
Acquisitions0.000.000.000.000.00
Purchases of investments13.7M+137.7%5.77M-43.4%10.2M-74.0%39.2M-42.9%68.7M-11.7%
10.5M+358.5%2.29M+17.2%1.95M+8.9%1.79M-91.2%20.5M-49.5%
Long-term debt issued0.000.000.000.00-100.0%15.0M-57.1%
Long-term debt repaid0.000.000.000.000.00
Common stock issued0.000.000.000.000.00-100.0%
Common stock repurchased0.000.000.000.000.00
Dividends paid0.000.000.000.000.00
Net change in cash5.99M+272.6%-3.47M-122.4%15.5M+188.7%-17.5M-5.2%-16.6M-219.6%
Interest paid6.81M-6.7%7.30M+275.6%1.94M0.00-100.0%495K-39.8%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap1.70B+132.4%731M+148.6%294M-30.3%422M+7.8%392M-46.3%
P/S7.5×+93.4%3.9×+102.0%1.9×-38.7%3.2×+2.5%3.1×-52.6%
P/B13.2×+87.4%7.0×+134.0%3.0×-27.7%4.2×+19.6%3.5×-41.2%
P/FCF
—509.6×———
FCF yield
—0.20%———
Source filing10-K10-K10-K10-K10-K

About this data

Source: AXGN’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all AXGN filings on SEC EDGAR → Not investment advice.